| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1826 | 2020 |
| Mechanism of blood coagulation by nonthermal atmospheric pressure dielectric barrier discharge plasma SU Kalghatgi, G Fridman, M Cooper, G Nagaraj, M Peddinghaus, ... IEEE Transactions on plasma science 35 (5), 1559-1566, 2007 | 439 | 2007 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 284 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| A phase I trial of BKM120 (Buparlisib) in combination with fulvestrant in postmenopausal women with estrogen receptor–positive metastatic breast cancer CX Ma, J Luo, M Naughton, F Ademuyiwa, R Suresh, M Griffith, OL Griffith, ... Clinical cancer research 22 (7), 1583-1591, 2016 | 98 | 2016 |
| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of oncology 33 (3), 340-346, 2022 | 89 | 2022 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature S Shaheen, H Mirshahidi, G Nagaraj, CT Hsueh Experimental Hematology & Oncology 7, 1-5, 2018 | 46 | 2018 |
| Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer G Nagaraj, C Ma Breast cancer research and treatment 150, 231-242, 2015 | 46 | 2015 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 38 | 2021 |
| Review of ongoing clinical trials in non–small-cell lung cancer: a status report for 2012 from the ClinicalTrials. gov web site J Subramanian, T Regenbogen, G Nagaraj, A Lane, S Devarakonda, ... Journal of Thoracic Oncology 8 (7), 860-865, 2013 | 38 | 2013 |
| AhR ligand aminoflavone suppresses α6‐integrin–Src–Akt signaling to attenuate tamoxifen resistance in breast cancer cells PS Campbell, N Mavingire, S Khan, LK Rowland, JV Wooten, ... Journal of cellular physiology 234 (1), 108-121, 2019 | 36 | 2019 |
| Clinical challenges in the management of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: a literature review G Nagaraj, CX Ma Advances in therapy 38 (1), 109-136, 2021 | 33 | 2021 |
| Association of sociodemographic factors with immunotherapy receipt for metastatic melanoma in the US JT Moyers, A Patel, W Shih, G Nagaraj JAMA Network Open 3 (9), e2015656-e2015656, 2020 | 33 | 2020 |
| Disparities in breast cancer: a multi‐institutional comparative analysis focusing on American Hispanics Z Nahleh, S Otoukesh, HR Mirshahidi, AL Nguyen, G Nagaraj, G Botrus, ... Cancer medicine 7 (6), 2710-2717, 2018 | 32 | 2018 |
| Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19 Z Bakouny, C Labaki, P Grover, J Awosika, S Gulati, CY Hsu, ... JAMA oncology 9 (1), 128-134, 2023 | 29 | 2023 |
| Applications of non thermal atmospheric pressure plasma in medicine S Kalghatgi, D Dobrynin, G Fridman, M Cooper, G Nagaraj, ... Plasma Assisted Decontamination of Biological and Chemical Agents, 173-181, 2008 | 27 | 2008 |
| A systematic framework to rapidly obtain data on patients with cancer and COVID-19: CCC19 governance, protocol, and quality assurance M Abidi, DM Aboulafia, MK Accordino, JD Acoba, MS Ahluwalia, ... Cancer cell 38 (6), 761-766, 2020 | 18 | 2020 |
| Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases JT Moyers, EG Chong, J Peng, HHC Tsai, D Sufficool, D Shavlik, ... Cancer Medicine 10 (4), 1201-1211, 2021 | 17 | 2021 |
| Adjuvant chemotherapy decisions in clinical practice for early-stage node-negative, estrogen receptor-positive, HER2-negative breast cancer: challenges and considerations G Nagaraj, CX Ma Journal of the National Comprehensive Cancer Network 11 (3), 246-251, 2013 | 17 | 2013 |
